β-Gal inhibitors encompass a varied collection of organic compounds distinguished by their capacity to obstruct the catalytic performance of β-galactosidase enzymes. These enzymes, prominently present in various organisms, orchestrate the hydrolytic cleavage of glycosidic linkages in β-galactoside substrates, yielding constituent monosaccharides. The inhibitors within this chemical class manifest a propensity to disrupt the regular functionality of β-galactosidase through a range of strategies, often involving their interaction with critical binding sites, such as the active site or functionally consequential regions. Originating from diverse sources, including both natural reservoirs and synthetic pathways, these inhibitors boast a rich diversity in their chemical architectures and mechanisms of action. These attributes, in turn, confer upon them the capacity to competitively or non-competitively impede the binding of substrates and the ensuing hydrolysis events. The intricate interplay between the structural attributes of these inhibitors and the specific amino acid residues constituting the enzyme's active site assumes a central role in dictating their efficacy as inhibitors.
These inhibitors, while intrinsically valuable for their role in modifying enzymatic activity, have also become indispensable tools in an array of research endeavors. Their deployment has significantly advanced the comprehension of enzymatic mechanisms, shedding light on the intricate steps involved in glycosidic bond cleavage. By perturbing the enzymatic function, these inhibitors facilitate the dissection of the substrate recognition process, unraveling the nuances of binding interactions that underscore catalysis. This, in turn, has yielded profound insights into fundamental biological processes, particularly those underpinned by glycosidic transformations. As a consequence, the realm of β-Gal inhibitors emerges as a dynamic domain, where chemical diversity intertwines with enzymatic intricacies to unravel the subtle choreography of glycoside hydrolysis.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Phloridzin dihydrate | 7061-54-3 | sc-215708 sc-215708A | 250 mg 1 g | $49.00 $119.00 | ||
A natural compound found in apple trees and related plants, Phloridzin inhibits β-galactosidase by competitively binding to the enzyme's active site. | ||||||
Castanospermine | 79831-76-8 | sc-201358 sc-201358A | 100 mg 500 mg | $184.00 $632.00 | 10 | |
This alkaloid inhibits β-galactosidase through its interaction with the enzyme's glycone pocket, preventing substrate binding. | ||||||
Deoxynojirimycin | 19130-96-2 | sc-201369 sc-201369A | 1 mg 5 mg | $73.00 $145.00 | ||
Deoxynojirimycin is a naturally occurring iminosugar that acts as a β-galactosidase inhibitor by binding to the active site and preventing substrate hydrolysis. | ||||||
Lactose | 63-42-3 | sc-221828A sc-221828 sc-221828B | 500 g 1 kg 2.5 kg | $109.00 $160.00 $352.00 | 1 | |
Paradoxically, lactose itself can act as a competitive inhibitor of β-galactosidase, especially when present in high concentrations. | ||||||
N-Butyldeoxynojirimycin·HCl | 210110-90-0 | sc-201398 sc-201398A sc-201398B | 5 mg 25 mg 50 mg | $180.00 $550.00 $985.00 | 4 | |
N-Butyldeoxynojirimycin·HCl is a potential inhibitor of β-galactosidase. | ||||||
Kifunensine | 109944-15-2 | sc-201364 sc-201364A sc-201364B sc-201364C | 1 mg 5 mg 10 mg 100 mg | $135.00 $540.00 $1025.00 $6248.00 | 25 | |
Kifunensine is an alkaloid that acts as an inhibitor of β-galactosidase by binding to its active site and preventing substrate hydrolysis. | ||||||